Polytechnic University of Madrid   Report issue

Academic/Hospital Phase 2
Founded: Madrid Spain (1971)

Organization Overview

First Clinical Trial
2009
NCT01576094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Bio-Engineer and Nanotechnology Dept., Polytechnic University of Madrid | INEF- Universidad Politecnica de Madrid | Univerdidad Politécnica de Madrid | Universidad Politecnica de Madrid | Universidad Politécnica de Madrid. | Universidad Politécnica de Madrid (UPM)

Active Ingredients

Drugs in Phase 2 Trials (3)

angelica (1 trial)

levosimendan (1 trial)

milrinone (primacor) (1 trial)

Drugs in Other Trials (1)

beetroot juice (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiac Output, Low (Phase 2)

Nocturia (Phase 2)

Urinary Bladder, Overactive (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 4